المؤلفون: Wahiba Oualikene-Gonin, Marie-Christine Jaulent, Jean-Pierre Thierry, Sofia Oliveira-Martins, Laetitia Belgodère, Patrick Maison, Joël Ankri, The Scientific Advisory Board of ANSM

المصدر: Frontiers in Pharmacology, Vol 15 (2024)

مصطلحات موضوعية: artificial intelligence, health policy, regulatory science, drug lifecycle, drug approval process, patient safety, Therapeutics. Pharmacology, RM1-950

وصف الملف: electronic resource

Relation: https://www.frontiersin.org/articles/10.3389/fphar.2024.1437167/full; https://doaj.org/toc/1663-9812

URL الوصول: https://doaj.org/article/e9a66d962c6945b595e71f8d02bb1e6b

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

المؤلفون: Bloem, Lourens T., Karomi, Mariana, Hoekman, Jarno, van der Elst, Menno E., Leufkens, Hubert G.M., Klungel, Olaf H., Mantel-Teeuwisse, Aukje K., Afd Pharmacoepi & Clinical Pharmacology, Innovation and Sustainability, Innovation Studies, Pharmacoepidemiology and Clinical Pharmacology

المصدر: Expert Opinion on Drug Safety, 20(11), 1433. Informa Healthcare

مصطلحات موضوعية: Drug, Time Factors, Drug-Related Side Effects and Adverse Reactions, media_common.quotation_subject, Cohort Studies, Government Agencies, Pharmacovigilance, European Medicines Agency, Simultaneous learning, Humans, Medicine, drug lifecycle, Pharmacology (medical), European Union, Drug reaction, Adverse effect, Drug Approval, Drug Labeling, Retrospective Studies, media_common, clinical trials, Public economics, business.industry, General Medicine, Patient exposure, benefit-risk, Drug regulation, Clinical trial, Drug development, pharmacovigilance, adverse effects, Drug and Narcotic Control, business, regulatory data

وصف الملف: application/pdf

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bf431b0e4a07a0501db64b120adaffe6
https://dspace.library.uu.nl/handle/1874/413000

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

المؤلفون: Bloem LT; Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands.; Pharmacovigilance department, Dutch Medicines Evaluation Board, Utrecht, The Netherlands., Karomi M; Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands., Hoekman J; Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands.; Pharmacovigilance department, Innovation Studies, Copernicus Institute of Sustainable Development, Utrecht University, Utrecht, The Netherlands., van der Elst ME; Pharmacovigilance department, Dutch Medicines Evaluation Board, Utrecht, The Netherlands., Leufkens HGM; Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands., Klungel OH; Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands.; Faculty of Health Sciences, University of Southern Denmark, Odense, Denmark., Mantel-Teeuwisse AK; Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands.

المصدر: Expert opinion on drug safety [Expert Opin Drug Saf] 2021 Nov; Vol. 20 (11), pp. 1433-1442. Date of Electronic Publication: 2021 Jul 15.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Taylor & Francis Country of Publication: England NLM ID: 101163027 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1744-764X (Electronic) Linking ISSN: 14740338 NLM ISO Abbreviation: Expert Opin Drug Saf Subsets: MEDLINE

مواضيع طبية MeSH: Drug Approval/*legislation & jurisprudence , Drug Labeling/*legislation & jurisprudence , Drug and Narcotic Control/*legislation & jurisprudence , Drug-Related Side Effects and Adverse Reactions/*epidemiology, Cohort Studies ; European Union ; Government Agencies ; Humans ; Retrospective Studies ; Time Factors